These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review. Maloney NJ; Ravi V; Cheng K; Bach DQ; Worswick S Int J Dermatol; 2020 Jun; 59(6):e183-e188. PubMed ID: 32052409 [TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson Syndrome-Like Reaction After Exposure to Pembrolizumab and Recombinant Zoster Vaccine in a Patient With Metastatic Lung Cancer. Riano I; Cristancho C; Treadwell T J Investig Med High Impact Case Rep; 2020; 8():2324709620914796. PubMed ID: 32207346 [TBL] [Abstract][Full Text] [Related]
10. Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma. Gallo Marin B; Oliva R; Kahn B; Borgovan T; Brooks BE; Massoud CM R I Med J (2013); 2022 Apr; 105(3):34-36. PubMed ID: 35349618 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous Stevens Johnson - Toxic Epidermal Necrolysis Immunotherapy related Toxicities in Lung Cancer Patients. Alexandris D; Alevizopoulos N; Gakiopoulou H; Stavrinou N; Vourlakou C J Oncol Pharm Pract; 2022 Jul; 28(5):1276-1282. PubMed ID: 35038934 [TBL] [Abstract][Full Text] [Related]
12. SJS/TEN immune-related dermatologic reaction secondary to immune checkpoint inhibitor pembrolizumab in skin of color. Pierre AB; Jernigan AM; Castellano T Gynecol Oncol Rep; 2023 Dec; 50():101290. PubMed ID: 37868017 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Schneider JA; Cohen PR Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852 [TBL] [Abstract][Full Text] [Related]
15. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report. Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493 [TBL] [Abstract][Full Text] [Related]
16. Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab. Lopez M; Hagopian G; Doan L; Lee BJ; Rojek NW; Smith J; Ou SI; Demirdag YY; Nagasaka M Allergy Asthma Clin Immunol; 2023 Oct; 19(1):93. PubMed ID: 37898814 [TBL] [Abstract][Full Text] [Related]
17. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Chen J; Wang B; Zeng Y; Xu H Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352 [TBL] [Abstract][Full Text] [Related]
18. Steven-Johnson Syndrome: A Rare but Serious Adverse Event of Nivolumab Use in a Patient With Metastatic Gastric Adenocarcinoma. Saad E; Adhikari P; Antala D; Abdulrahman A; Begiashvili V; Mohamed K; Ali E; Zhang Q J Med Cases; 2022 Sep; 13(9):449-455. PubMed ID: 36258702 [TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit. Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430 [TBL] [Abstract][Full Text] [Related]
20. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China. Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]